InsidersTradesSigma
Follow the Genmab A/S share price and the full management transaction log of the company, a publicly traded company based in Denmark. Shares are quoted on the DK market, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Genmab A/S has published 141 reports. Market capitalisation: €117.3bn. The latest transaction was reported on 29 May 2026 (Sale). All data is free.
141
Insider Decl.
n/a
Thresholds
€9m
16 ops.
Buy Volume
€33m
26 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Genmab A/S Buy (bullish), based on 15 analysts. Average price target: DKK 2,392.08.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,219 of 28,753 companies
55.8
score / 100
Value40
Quality72
FCF yld0.8%
Earn yld0.7%
EV/EBITDA·
ROE14%
Gross mgn94%
Net mgn26%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 May 2026
Declarations141 total
221 shares@ DKK 1,734.750.0000% mcap100.0% of flowShareXCSEISIN DK0010272202DK:1445447
8,525 shares@ DKK 1,758.500.0016% mcap4.6% of flowShareOutside the marketISIN DK0010272202DK:1430992
6 shares@ DKK 1.800.0% of flowShareOutside the marketISIN DK0010272202DK:1423836
567 shares0ShareOutside the marketISIN DK0010272202DK:1423824
33,293 shares0ShareOutside the marketISIN DK0010272202DK:1423440
899 shares@ DKK 1,810.000.0002% mcap0.5% of flowShareXCSEISIN DK0010272202DK:1421715
378 shares@ DKK 2,043.000.0001% mcap0.2% of flowShareOutside a market placeISIN DK0010272202DK:1403941
42 shares@ DKK 1,960.500.0000% mcap0.0% of flowShareAQEUISIN DK0010272202DK:1401641
23,266 shares@ DKK 1,025.000.0026% mcap7.3% of flowShareOutside the marketISIN DK0010272202DK:1387733
24 shares@ DKK 1,485.000.0000% mcap0.0% of flowShareXCSEISIN DK0010272202DK:1371150
996 shares0ShareOutside a market placeISIN DK0010272202DK:1352989
1,311 shares0ShareOutside the marketISIN DK0010272202DK:1348625
5,078 shares0ShareOutside a market placeISIN DK0010272202DK:1346934
36,373 shares0ShareOutside the marketISIN DK0010272202DK:1346363
454 shares0ShareOutside a market placeISIN DK0010272202DK:1331369
24,461 shares@ DKK 1,032.000.0027% mcap7.7% of flowShareOutside the marketISIN DK0010272202DK:1310577
6 shares@ DKK 1,914.000.0000% mcap0.0% of flowShareAQEUISIN DK0010272202DK:1301181
837 shares0ShareOutside the marketISIN DK0010272202DK:1280998
7,000 shares@ DKK 27.78810.0000% mcap0.1% of flowShareXNASISIN US3723032062DK:1279104
5,630 shares0ShareOutside a market placeISIN DK0010272202DK:1278822
11,299 shares@ DKK 1,942.860.0024% mcap6.7% of flowShareAquis Exchange (AQEA, AQED, AQEU)ISIN DK0010272202DK:1278470
5,147 shares@ DKK 1,025.000.0006% mcap1.6% of flowShareOutside the marketISIN DK0010272202DK:1277786
27,404 shares0ShareOutside the marketISIN DK0010272202DK:1277173
335 shares0ShareOutside a market placeISIN DK0010272202DK:1267553
559 shares0ShareOutside the marketISIN DK0010272202DK:1260557
25 of 141 declarations
About Genmab A/S
Genmab A/S is a Danish biopharmaceutical company focused on developing therapeutic antibodies for cancer treatment. It is listed on the Copenhagen Stock Exchange.
